XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations - Additional information (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 06, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net incremental loss on the sale of MedData   $ (680,036) $ (28,292) $ (684,999) $ (293,710)
North American Partners In Anesthesia [Member]          
Preliminary and incremental gain loss on sale   644,200      
Increase decrease in valuation allowance deferred tax assets   419,000      
Proceeds from Divestiture of Businesses $ 50,000        
Maximum consideration receivable 250,000        
Accounts receivable retained 110,000        
North American Partners In Anesthesia [Member] | Tax Year Two Thousand and Twenty Five [Member]          
Capital loss carry forward   1,680,000   1,680,000  
North American Partners In Anesthesia [Member] | Maximum [Member]          
Maximum consideration receivable 250,000        
North American Partners In Anesthesia [Member] | Minimum [Member]          
Maximum consideration receivable $ 0        
Divestiture of MedData [Member]          
Net incremental loss on the sale of MedData   $ 3,000   $ 5,600